Who Paid My Doc Search
Menu
Product Program year 2025 Source: CMS Open Payments

HANAROSTENT Biliary (NNN)

Device EndoTherapy

PDI 08806367017581

Open in the dashboard

General payments

$361,903

106 payments

Research payments

$0

0 payments

Through program year 2025, $361,903 in general payments and $0 in research payments were reported against HANAROSTENT Biliary (NNN) (EndoTherapy).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $342,747 84
2022 General $19,156 22

Breakdown

Who paid General payments · program years 2022–2025
  1. Olympus Corporation of the Americas $339,875 51 payments
  2. Olympus America Inc. $12,528 48 payments
  3. Olympus Medical Systems Corporation $9,500 7 payments
Top recipients General payments · program year 2025
  1. U Of U Hospitals & Clinics Teaching hospital · UT $177,830 52% · 1 payment
  2. Adventhealth Orlando Teaching hospital · FL $137,759 40% · 1 payment
  3. The University Of Texas Medical Br. Teaching hospital · TX $5,253 2% · 1 payment
  4. Gregory Haber Gastroenterology · New York, NY $3,310 <1% · 5 payments
  5. Andrew Storm Gastroenterology · Winston Salem, NC $1,504 <1% · 4 payments

The top 5 of 56 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Gastroenterology Internal Medicine $17,287 83% · 38 practitioners
  2. Transplant Hepatology Internal Medicine $1,500 7% · 1 practitioner
  3. Surgery $1,196 6% · 3 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $635 3% · 3 practitioners
  5. Infectious Disease Internal Medicine $108 <1% · 1 practitioner

The top 5 of 10 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Utah $177,830 52% · 1 recipient
  2. Florida $138,955 41% · 4 recipients
  3. Massachusetts $8,000 2% · 6 recipients
  4. Texas $5,439 2% · 4 recipients
  5. New York $4,029 1% · 3 recipients

The top 5 of 18 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

Records

106 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record